Doruxapapogene ralaplasmid

N/A

Report date: 2026/04/15 20:02:38

Base Information

Drug NameDoruxapapogene ralaplasmid
Drug Alias NameINO-3106INO-3107
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRespiratory papillomatosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pennsylvania
China Registration ClassN/A

Develop Information

Inactive CompaniesUniversity Of Pennsylvania
Active IndicationsRespiratory papillomatosis
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A